• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369

Heptanal,2-(2,4-dinitrophenyl)hydrazone: Chemical Profile and Recent Research Applications

Heptanal,2-(2,4-dinitrophenyl)hydrazone is a specialized organic compound characterized by its unique structural and chemical properties. This compound, identified by the CAS number 2074-05-7, has garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications. The molecular structure of Heptanal,2-(2,4-dinitrophenyl)hydrazone incorporates a heptanal moiety linked to a 2,4-dinitrophenyl group through a hydrazone bridge. This configuration imparts distinct reactivity and functionality, making it a valuable intermediate in synthetic chemistry and a potential candidate for various biological assays.

The synthesis of Heptanal,2-(2,4-dinitrophenyl)hydrazone involves a carefully controlled reaction between heptanal and 2,4-dinitrophenylhydrazine. The reaction conditions must be optimized to ensure high yield and purity, often requiring precise temperature control and stoichiometric ratios. Advanced synthetic methodologies have been developed to enhance the efficiency of this process, leveraging techniques such as catalytic hydrogenation and protective group strategies to minimize side reactions.

In recent years, Heptanal,2-(2,4-dinitrophenyl)hydrazone has been explored for its potential in drug discovery and development. Its structural features make it an attractive scaffold for designing novel bioactive molecules. Specifically, the presence of the 2,4-dinitrophenyl group enhances its interaction with biological targets due to its electron-withdrawing nature and ability to form hydrogen bonds. This property has been exploited in the design of inhibitors targeting enzymes involved in metabolic pathways relevant to diseases such as diabetes and cancer.

One of the most compelling applications of Heptanal,2-(2,4-dinitrophenyl)hydrazone is in the development of chemosensitizers for cancer therapy. Research has demonstrated that this compound can enhance the efficacy of conventional chemotherapeutic agents by increasing their accumulation at tumor sites and improving their ability to induce apoptosis in cancer cells. The mechanistic insights into these effects have revealed that the hydrazone moiety plays a crucial role in modulating cellular signaling pathways associated with tumor growth and survival.

The compound's potential extends beyond oncology; it has also been investigated for its antimicrobial properties. Studies have shown that Heptanal,2-(2,4-dinitrophenyl)hydrazone exhibits activity against a range of bacterial and fungal strains by disrupting essential cellular processes. This finding is particularly significant in the context of rising antibiotic resistance, where novel antimicrobial agents are urgently needed. The structural diversity offered by this compound allows for further derivatization to enhance its bioactivity and broaden its therapeutic spectrum.

The use of computational chemistry has further advanced the understanding of Heptanal,2-(2,4-dinitrophenyl)hydrazone's interactions with biological targets. Molecular modeling techniques have been employed to predict binding affinities and identify key residues involved in receptor-ligand interactions. These insights have guided the rational design of analogs with improved pharmacokinetic profiles and reduced toxicity. Such computational approaches are integral to modern drug discovery pipelines, enabling researchers to accelerate the development of lead compounds.

Evaluation of the toxicological profile of Heptanal,2-(2,4-dinitrophenyl)hydrazone is essential for assessing its safety in preclinical and clinical settings. Preliminary studies have indicated that the compound exhibits low systemic toxicity at therapeutic doses, although further investigation is required to fully characterize its safety profile. Acute toxicity studies have shown minimal adverse effects on major organ systems when administered at high doses comparable to those expected in clinical use. Additionally, chronic toxicity assessments are being conducted to evaluate long-term exposure risks.

The regulatory landscape for pharmaceutical compounds like Heptanal,2-(2,4-dinitrophenyl)hydrazone is stringent but well-established. Compliance with guidelines set forth by agencies such as the FDA and EMA is necessary for advancing this compound through clinical trials and eventual market approval. Regulatory submissions require comprehensive data on synthesis methodology, analytical characterization, pharmacological activity, toxicology results, and manufacturing processes. Collaborative efforts between academic researchers and industry partners are often required to meet these stringent requirements efficiently.

The future prospects for Heptanal,2-(2,4-dinitrophenyl)hydrazone are promising given its diverse applications in medicinal chemistry and biotechnology. Ongoing research aims to optimize its synthetic routes for scalability while exploring novel derivatives with enhanced therapeutic potential. Advances in biocatalysis may also enable greener synthetic methods that align with sustainable chemistry principles. As our understanding of disease mechanisms evolves，the role of innovative compounds like this one will continue to expand.

• 2348-19-8(Nonanal,2-(2,4-dinitrophenyl)hydrazone)
• 1527-97-5(Hexanal 2,4-dinitrophenylhydrazone)
• 1726-82-5(2,4-dinitro-n-[(e)-tetradecylideneamino]aniline)
• 79058-63-2(N-[8-[(2,4-dinitrophenyl)hydrazinylidene]octylideneamino]-2,4-dinitroaniline)
• 2700-68-7(Pentadecanal,2-(2,4-dinitrophenyl)hydrazone)
• 2423-05-4(Hexadecanal,2-(2,4-dinitrophenyl)hydrazone)
• 1726-77-8(Octanal,2-(2,4-dinitrophenyl)hydrazone)
• 1726-78-9(Dodecanal,2-(2,4-dinitrophenyl)hydrazone)
• 2057-84-3(Valeraldehyde-2,4-dinitrophenylhydrazone)
• 1527-95-3(Decanal,2-(2,4-dinitrophenyl)hydrazone)